CD38 and Miyoshi myopathy: In contrast, compared to CARTITUDE‐1, the RW cohort had a greater proportion of patients who were penta‐refractory (to at least two IMiDs, at least two PIs, and an anti‐CD38 MoAB) or who had been diagnosed with MM less than 6 years prior.